Smoore International reported Q1 2023 revenue of RMB 2.5b and net profit of RMB 3b, both below our full-year estimates of RMB 16b and RMB 10b respectively. China region revenue decreased by 98% due to strong sales of refillable e-cigarettes in Europe, while overseas revenue grew by 58%. The decline was more severe than expected, with the market down 80-90% from Q1 2022 when fruity refillables were still legal. We believe this result may reignite concerns about the recovery of Smoore and RLX, and their stocks have corrected by 3%+ in the past 10 trading days. We will monitor their Q2 recovery trajectory. Our revenue estimates are in line with market consensus, but we maintain our estimates, which are 5-10% lower than consensus. Our valuation reflects current confusion over pricing the revised business outlook after the new regulations come into effect, and we now use the average valuation from the IPO until March 2022. Our target price remains at RMB 21.5x FY23E P/E, 1sd below average valuation. The current valuation is near historical lows, and we believe regulatory risks are well reflected. Maintain Buy.
找报告就上发现报告（www.fxbaogao.com），这是一个资源超级丰富的专业平台。我们的用户群体庞大，深受投资者信赖。研报内容覆盖面极广，宏观、行业、公司报告应有尽有，数量巨大。我们专注于提升您的效率，界面简单好用，技术强大，帮您迅速获取关键信息。在这里，您可以深度洞察市场，做出最精准的投资判断。
